Sars-cov-2 mrna-vaccine candidate; corenapcin®, induces robust humoral and cellular immunity in mice and non-human primates

HIGHLIGHTS

• who: Reza Alimohammadi from the (UNIVERSITY) have published the article: SARS-CoV-2 mRNA-vaccine candidate; COReNAPCINu00ae, induces robust humoral and cellular immunity in mice and non-human primates, in the Journal: (JOURNAL) of 12/08/2022

SUMMARY

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the beta coronavirus genus, and since its emergence in 2019 leads to hundreds of millions coronavirus disease 2019 (COVID-19) cases and several millions of deaths so far1,2. Despite of rapid development of vaccines against SARS-CoV-2, there is still . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.